medigraphic.com
SPANISH

Revista Habanera de Ciencias Médicas

ISSN 1729-519X (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 6

<< Back Next >>

Revista Habanera de Ciencias Médicas 2022; 21 (6)

Diagnosis and treatment of acute pulmonary embolism during pregnancy

Vázquez HG, Vasallo PR, Toledo PY
Full text How to cite this article

Language: Spanish
References: 20
Page: 1-6
PDF size: 379.34 Kb.


Key words:

pulmonary embolism, pregnancy, heparin, fibrinolysis, risk prediction.

ABSTRACT

Introduction: Acute pulmonary embolism is one of the most frequent causes of mortality and serious morbidity during pregnancy; however, there is no consensus on its definitive diagnosis.
Objective: To expose the most important considerations for the diagnosis and treatment of pregnant women with suspected pulmonary embolism.
Material and Methods: Literature review on the subject, published from 2012 to the present, which included the PubMed/MEDLINE, EMBASE, Lilacs and SciELO databases.
Development: The current guidelines show controversies in relation to the use of risk prediction rules, the quantification of D-dimer and the indication of imaging studies. Clinical evaluation continues to be the main diagnostic substrate, but it has been pointed out that both a normal ventilation-perfusion scintigraphy and a negative CT angiography accurately exclude pulmonary embolism during pregnancy. The use of heparins is the treatment of choice, while the new oral anticoagulants are not recommended in pregnancy due to the lack of studies that support their safety. Fibrinolysis can be considered in high-risk pregnant women (severe hypotension, shock, or cardiorespiratory arrest).
Conclusions: The management of these patients should be undertaken by a multidisciplinary team, which will allow better maternal and perinatal results.


REFERENCES

  1. Samuel W, Giunco E, de Castro M, Gomez A, Márquez C, Vilas C, et al. Posicionamento da Sociedade Brasileira de Cardiologia para Gravidez e Planejamento Familiar na Mulher Portadora de Cardiopatia - 2020. Arq Bras Cardiol [internet]. 2020 [Citado 28/11/2022];114(5):849-942. Disponible en: https: //doi.org/10.36660/abc.202004061.

  2. Hobohm L, Farmakis IT, Münzel T, Konstantinides Keller K. Pulmonary Embolism and Pregnancy-Challenges in Diagnostic and Therapeutic Decisions in High-Risk Patients. Cardiovasc Med [internet]. 2022 [Citado 28/11/2022];9:856594. Disponible en: https://www.frontiersin.org/articles/10.3389/fcvm.2022.856594/full2.

  3. Pérez Domínguez J, Ortega Varon Y, Leblanch Pérez L, Medel Avilés O, Rodríguez Peña M. Factores influyentes en la muerte por tromboembolismo pulmonar. MULTIMED [Internet]. 2021 [Citado 28/11/2022];25(3). Disponible en: http://www.revmultimed.sld.cu/index.php/mtm/article/view/19743.

  4. Vera J, Roos J, Bauersachs C, Blomströmt R, Cífková M, De Bonis M, et al. Guía ESC 2018 sobre el tratamiento de las enfermedades cardiovasculares durante el embarazo. Rev Esp Cardiol [internet]. 2019 [Citado 28/11/2022];72(2):161.e1-e65. Disponible en: http://doi.org/10.1016/j.recesp.2018.12.0044.

  5. Robert Ebadi H, Le Gal G, Righini M. Diagnostic Management of Pregnant Women With Suspected Pulmonary Embolism. Front Cardiovasc Med [Internet]. 2022 [Citado 28/11/2022];9:851985. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967345/5.

  6. Moussa HN, Rajapreyar I. ACOG practice: pregnancy and heart disease. Obstet Gynecol [Internet] 2019;134 (4):881-2. Disponible en: https: //pubmed.ncbi.nlm.nih.gov/310222123

  7. Muryán S, Malvino E. Cuidados intensivos cardiológicos en pacientes obstétricas. 2 ed [Internet]. Argentina: Obstericiacritica; 2020 [Citado 28/11/2022]. Disponible en: Disponible en: www.obstetriciacritica.com 7.

  8. Freund Y, Cohen Aubart F, Bloom B. Acute pulmonary embolism: A review: A review. JAMA [Internet].2022;328(13):1336-45. Disponible en: http://dx.doi.org/10.1001/jama.2022.168158.

  9. Robert Ebadi H, Moumneh T, Le Gal G, Righini M. Diagnosis of Pulmonary Embolism during Pregnancy. Diagnostics (Basel) [Internet]. 2022;12(8):1875. Disponible en: http://dx.doi.org/10.3390/diagnostics120818759.

  10. Van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet [Internet]. 2017;390(10091):289-97. Disponible en: http://dx.doi.org/10.1016/s0140-6736(17)30885-110.

  11. Meng K, Hu X, Peng X, Zhang Z. Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis. J Matern Fetal Neonatal Med [Internet]. 2015;28(3):245-53. Disponible en: http://dx.doi.org/10.3109/14767058.2014.91313011.

  12. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J [Internet]. 2020;41(4):543-603. Disponible en: http://dx.doi.org/10.1093/eurheartj/ehz40512.

  13. Sheen JJ, Haramati LB, Natenzon A, Ma H, Tropper P, Bader AS, et al. Performance of low-dose perfusion scintigraphy and CT pulmonary angiography for pulmonary embolism in pregnancy. Chest [Internet]. 2018;153(1):152-60. Disponible en: http://dx.doi.org/10.1016/j.chest.2017.08.00513.

  14. Zipes DP, Bonow RO, Brauwald E. Embolia pulmonar. En su: Brauwald Tratado de Cardiología: Texto de Medicina Cardiovascular. 11 ed. Madrid: Elsevier; 2019. pp. 3567-9.

  15. Martillotti G, Boehlen F, Robert Ebadi H, Jastrow N, Righini M, Blondon M. Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review. J Thromb Haemost [Internet]. 2017;15(10):1942-50. Disponible en: http://dx.doi.org/10.1111/jth.1380215.

  16. Sharma G, Ying W, Silversides C. The Importance of Cardiovascular Risk Assessment and Pregnancy Heart Team in the Management of Cardiovascular Disease in Pregnanc. Cardiol Clin [internet]. 2021;39:7-19. Disponible en: https://doi.org/10.1016/j.ccl.2020.09.00216.

  17. Sandoval J, Sandoval C. Uso de fármacos durante el embarazo. Horiz Med [Internet]. 2018 [Citado 28/11/2022];18(2):71-9. Disponible en: http://dx.doi.org/10.24265/horizmed.2018.v18n2.1117.

  18. Camacho A, Méndez A, Martín A. Eventos tromboembólicos y el embarazo: actualización en anticoagulación en mujeres embarazadas. Rev méd sinerg [Internet]. 2019 [Citado 28/11/2022];4(5):77-88. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/21018.

  19. Durán M, Ariza J, Colonia A. Manejo de la terapia anticoagulante durante el embarazo. Medicas UIS [Internet]. 2020 [Citado 28/11/2022];33(2):65-73. Disponible en: https://doi.org/10.18273/revmed.v33n2-202000719.

  20. Vera O. Farmacología básica y clínica de los anticoagulantes. Cuad Hosp Clín [Internet]. 2022 [Citado 28/11/2022];63(1):55-63. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S165267762022000100009&lng=es20.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Habanera de Ciencias Médicas. 2022;21